A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 ``PembroRad'' trial
Saved in:
Published in | Journal of clinical oncology Vol. 36; no. 15, S |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
American Society of Clinical Oncology
2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
ISSN: | 0732-183X 1527-7755 |
---|---|
DOI: | 10.1200/JCO.2018.36.15\_suppl.6018 |